Royal Bank of Canada’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Royal Bank of Canada’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,349	Closed	-$395K	–	7839
2023 Q4	$395K	Buy	+6,349	New	+$158K	﹤0.01%	4477

Royal Bank of Canada's RYZB Position: Q1 2024 in Review

Royal Bank of Canada sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 6,349 shares — an estimated $395K sold.

Royal Bank of Canada first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $395K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Royal Bank of Canada reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Royal Bank of Canada sold 6,349 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $395K.
Royal Bank of Canada first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Royal Bank of Canada's RayzeBio, Inc. Common Stock position peaked at $395K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Royal Bank of Canada's 13F filing for Q1 2024, filed 15 May 2024.